Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

被引:59
作者
Brown, Lawrence S., Jr.
Kritz, Steven Allan
Goldsmith, R. Jeffrey
Bini, Edmund J.
Rotrosen, John
Baker, Sherryl
Robinson, Jim
McAuliffe, Patrick
机构
[1] Addict Res & Treatment Corp, Brooklyn, NY 11201 USA
[2] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY USA
[3] Univ Cincinnati, Cincinnati VA Med Ctr, Dept Psychiat, Cincinnati, OH USA
[4] VA New York Harbor Healthcare Syst, Dept Gastroenterol, New York, NY USA
[5] NYU, Sch Med, Dept Psychiat, New York, NY USA
[6] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA
[7] Connecticut Renaissance Inc, Norwalk, CT USA
关键词
HIV/AIDS; hepatitis C virus infection; sexually transmitted infections; National Drug Abuse Treatinent Clinical Trials Network; community treatment program;
D O I
10.1016/j.jsat.2006.02.006
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Illicit drug users sustain the epidemics of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hepatitis C (HCV), and sexually transmitted infections (STIs). Substance abuse treatment programs present a major intervention point in stemming these epidemics. As a part of the "Infections and Substance Abuse" study, established by the National Drug Abuse Treatment Clinical Trials Network, sponsored by National Institute on Drug Abuse, three surveys were developed; for treatment program administrators, for clinicians, and for state and District Of Columbia health and substance abuse department administrators, capturing service availability, government mandates. funding, and other key elements related to the three infection groups. Treatment programs varied in corporate structure, source of revenue, patient census, and medical and non-medical staffing; medical services, counseling services, and staff education targeted HIV/AIDS more often than HCV or STIs. The results from this study have the potential to generate hypotheses for further health services research to inform public policy. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 29 条
[1]  
[Anonymous], NCSS PASS
[2]   Risk and prevalence of treatable sexually transmitted diseases at a Birmingham Substance Abuse Treatment Facility [J].
Bachmann, LH ;
Lewis, I ;
Allen, R ;
Schwebke, JR ;
Leviton, LC ;
Siegal, HA ;
Hook, EW .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (10) :1615-1618
[3]  
BATTJES RJ, 1995, J ACQ IMMUN DEF SYND, V10, P90
[4]   A population-based study of sexually transmitted disease incidence and risk factors in human immunodeficiency virus-infected people [J].
Belongia, EA ;
Danila, RN ;
Angamuthu, V ;
Hickman, CD ;
DeBoer, JM ;
MacDonald, KL ;
Osterholm, MT .
SEXUALLY TRANSMITTED DISEASES, 1997, 24 (05) :251-256
[5]   HIV RISK-RELATED SEX BEHAVIORS AMONG INJECTION-DRUG USERS, CRACK SMOKERS, AND INJECTION-DRUG USERS WHO SMOKE CRACK [J].
BOOTH, RE ;
WATTERS, JK ;
CHITWOOD, DD .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1993, 83 (08) :1144-1148
[6]   Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995 [J].
Broers, B ;
Junet, C ;
Bourquin, M ;
Déglon, JJ ;
Perrin, L ;
Hirschel, E .
AIDS, 1998, 12 (15) :2059-2066
[7]  
Browning ME, 2002, PLAT SURF FINISH, V89, P10
[8]   HETEROSEXUAL TRANSMISSION OF HIV-1 ASSOCIATED WITH THE USE OF SMOKABLE FREEBASE COCAINE (CRACK) [J].
CHIASSON, MA ;
STONEBURNER, RL ;
HILDEBRANDT, DS ;
EWING, WE ;
TELZAK, EE ;
JAFFE, HW .
AIDS, 1991, 5 (09) :1121-1126
[9]   METHADONE TREATMENT AND ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
COOPER, JR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (12) :1664-1668
[10]   Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis [J].
Fortenberry, JD ;
Brizendine, EJ ;
Katz, BP ;
Wools, KK ;
Blythe, MJ ;
Orr, DP .
SEXUALLY TRANSMITTED DISEASES, 1999, 26 (01) :26-32